A detailed history of Jarislowsky, Fraser LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 14,083 shares of AZN stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,083
Previous 11,763 19.72%
Holding current value
$1.08 Million
Previous $792,000 20.45%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $141,589 - $161,402
2,320 Added 19.72%
14,083 $954,000
Q4 2023

Feb 12, 2024

SELL
$61.89 - $69.28 $4,579 - $5,126
-74 Reduced 0.63%
11,763 $792,000
Q3 2023

Nov 06, 2023

BUY
$64.85 - $71.7 $196,171 - $216,892
3,025 Added 34.33%
11,837 $801,000
Q2 2023

Jul 19, 2023

BUY
$69.91 - $75.81 $616,046 - $668,037
8,812 New
8,812 $630,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.